Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
2018 1
2020 1
Text availability
Article attribute
Article type
Publication date

Search Results

3 results
Results by year
Filters applied: . Clear all
Page 1
Taking cardiology clinical trials to the next level: A call to action.
Clayton JA, Arnegard ME. Clayton JA, et al. Clin Cardiol. 2018 Feb;41(2):179-184. doi: 10.1002/clc.22907. Epub 2018 Feb 26. Clin Cardiol. 2018. PMID: 29480590 Free PMC article. Review.
Because women who develop obstructive coronary heart disease and heart failure tend to do so 10 years later than men, cardiology clinical trials that use arbitrary age cutoffs or exclusion criteria based on comorbidities and polypharmacy often limit the pool …
Because women who develop obstructive coronary heart disease and heart failure tend to do so 10 years later than men, cardiology c
Effects of switching from a dipeptidyl peptidase-4 inhibitor to luseogliflozin on nocturnal blood pressure in patients with type 2 diabetes: protocol for a multicentre, prospective, randomised, open-label, blinded endpoint parallel-group comparison study.
Kameda R, Nomoto H, Cho KY, Kawata S, Omori K, Takeuchi J, Nagai S, Kurihara Y, Aoki S, Nakamura A, Atsumi T, Miyoshi H. Kameda R, et al. BMJ Open. 2020 Feb 6;10(2):e034883. doi: 10.1136/bmjopen-2019-034883. BMJ Open. 2020. PMID: 32034028 Free PMC article.
Sixty participants with T2D and hypertension who have been treated with a DPP-4 inhibitor for more than 4 weeks and who have a glycated haemoglobin A1c (HbA1c) level of 6.0%-9.0% will be randomised based on age, body mass index (BMI) and HbA1c to continue taking the …
Sixty participants with T2D and hypertension who have been treated with a DPP-4 inhibitor for more than 4 weeks and who have a glycated haem …
Methods of data analysis of ambulatory blood pressure monitoring in clinical trials.
de Gaudemaris R, Chau NP. de Gaudemaris R, et al. Blood Press Monit. 1996 Jun;1(3):259-262. Blood Press Monit. 1996. PMID: 10226240
The objectives of the analysis are to compare the blood pressure levels at different phases of the trial and to be sure that the effect will continue until the next dose. ...The methods of statistical analysis of the levels of blood pressure are dictated by t …
The objectives of the analysis are to compare the blood pressure levels at different phases of the trial and to be sure that the effe …
Feedback